Surrogate Mother Dies of Complications
By Times of India,
Times of India
| 05. 17. 2012
AHMEDABAD: Premila Vaghela, 30, had opted to become a surrogate mother and deliver child of a US-based couple to supplement her family income and brighten the future of her own two kids.
On Wednesday, Premila, who was eight months pregnant, died due to unexplained complications. But she completed her job - the child was delivered and is in the NICU recuperating from early birth.
Surrogacy has picked up majorly all over Gujarat where Anand is considered the global surrogacy capital. Ahmedabad too caters to a big number of couples who medically need a womb to carry their child. Couples are known to pay anywhere between Rs 2.5 lakh and Rs 4 lakh to women who offer their wombs on rent to conceive and deliver the child. The decent money offered by couples, majority of who are NRGs and foreigners, attracts many women from poor socio-economic backgrounds to offer themselves as surrogates.
Premila paid the price of offering herself as surrogate with her life. Dr Manish Banker of Pulse Hospital, where Premila was a surrogate, said that they are clueless as...
Related Articles
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Siddhi Mahatole and Mariam E. Sunny, Reuters | 06.13.2025
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' (REGN.O), opens new tab offer for the DNA-testing company in a bankruptcy auction.
Last month, Regeneron agreed to...